Loading...
Romidepsin Controls Chronic Lymphocytic Leukemia in a Patient with Mycosis Fungoides
Romidepsin belongs to a class of medications called histone deacetylase inhibitors and is currently approved for treatment of cutaneous and peripheral T-cell lymphomas. Romidepsin was previously investigated for the treatment of chronic lymphocytic leukemia (CLL), and demonstrated potential benefit,...
Na minha lista:
| Udgivet i: | Hematol Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
PAGEPress Publications, Pavia, Italy
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5136743/ https://ncbi.nlm.nih.gov/pubmed/27994839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2016.6840 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|